• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Isodiol International Inc. Announces Launch of Market’s First Hops-Derived CBD Products

    Investing News Network
    Oct. 23, 2017 11:10AM PST
    Cannabis Investing News
    CSE:ISOL

    Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce the launch of the market’s first non-cannabis, highly bioactive cannabinoid, CBD, derived from the hops plant; a globally accepted plant.

     Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and nutraceutical products, is pleased to announce the launch of the market’s first non-cannabis, highly bioactive cannabinoid, CBD, derived from the hops plant; a globally accepted plant. The cannabinoids are derived using proprietary genetics and extraction technology that allow for the isolation of the cannabinoids and terpenes without denaturing the molecule.
    Hops-derived cannabinoid products have shown a favorable response and promising results in independent clinical studies for various diseases. Sourcing natural, highly bioactive cannabinoids to supplement the endocannabinoid system in the human body is key to developing targeted health care remedies.
    “The development of the technology to extract cannabinoids from a plant other than cannabis, without denaturing the molecule is an incredible achievement,” said Marcos Agramont, CEO of Isodiol International. “As the regulatory framework within the US continues to mature, the establishment of a new non-cannabis source of CBD and the continued growth of our International pharmaceutical footprint will differentiate Isodiol as the global leader.”
    The Company will continue to collaborate with universities and alternative health facilities in the United States and overseas to validate the science. It anticipates products will be ready for distribution within the next 4 weeks.
    This announcement is on the heels of the Company’s introduction of it’s Phytoceutical Division on September 5, 2017. The press release can be found here.
    About Isodiol International Inc.
    Isodiol International Inc. is the market leader in pharmaceutical and nutraceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
    Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
    Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
    ON BEHALF OF THE BOARD
    “Marcos Agramont” CEO & Director
    INVESTOR RELATIONS:
    Ir@isodiol.com
    www.isodiol.com
    COMPANY MEDIA :
    Isodiol.com
    CBDnaturals.com
    Iso-sport.com
    CBDskincream.com
    Potocoffee.coffee
    Join Us On Facebook: https://www.facebook.com/Isodiol/
    Twitter: @isodiol
    MEDIA CONTACT:
    Carrie Booze
    North 6th Agency
    212-334-9753 ext.142
    Isodiol@n6a.com
    Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
    The CSE has not reviewed, approved or disapproved the content of this press release.
    Click here to connect with Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) for an Investor Presentation.

    Source: isodiol.com

    europecannabis investingcse:isolextraction technologyclinical studies
    The Conversation (0)

    Go Deeper

    AI Powered
    Person touching a cannabis plant; Australia map in flag colours.

    ASX Cannabis Stocks: 10 Biggest Companies in 2025

    Cannabis Investment: Canadian Cannabis Stocks

    Cannabis Investment: Canadian Cannabis Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×